Research Program for Molecular Neurology

Biomedicum 1
Haartmaninkatu 8
FIN-00290 Helsinki

Head of the program:
Anu Wartiovaara
anu.wartiovaara [at]
+358-9-471 71965

Project coordinator:
Maija Komonen
maija.komonen [at]

Research programs unit

Faculty of medicine


Molecular Neurology Research Program on Twitter


Premature cell differentiation leads to disorders in pancreatic development.

Meet Finland's new gene genie.

Taru Hilander from group Tyynismaa defended her doctoral thesis "Molecular Consequences of Transfer-RNA Charging Defects" in Biomedicum Helsinki 1, Lecture Hall 3, March 24, 2017 at 12.

Eliniän huomattava pidentäminen on mahdollista - mitkä keinot toimivat ihmisellä?

Förebilder hjälper att krossa glastaket.

Significant epilepsy gene discovery in dogs.

Yle Areena: Tiedeykkönen ja tasmäruoka hoitona täsmäpotilaalla.

HS: Atkinsin dieetti voi vaikuttaa dramaattisesti vaikeisiin lihassairauksiin.

Diet as medicine in mitochondrial diseases?

Professor Juha Kere has accepted the position of Professor of Genetics and Molecular Medicine at King's College London (KCL), Faculty of Life Sciences & Medicine, starting 1 September 2016.

Markus Sainio from group Tyynismaa is the P.K. Thomas prize winner for the best presentation "Modeling TRIM2 and other CMT2 mutations in patient-specific motor neurons" at the CMTR 2016 meeting.

New Academy Professors working on neuroscience and climate challenges.

Academy of Finland has selected Anu Wartiovaara as an Academy Professor.

Research project comparing canine and human genome receives significant support.

Henna Tyynismaa has received L’Oréal Finland's and Unesco's For Women in Science Award 2016.

Anu Wartiovaara is Faculty of Medicine's Alumni of the year 2016.

Riikka Jokinen from group Battersby defended her doctoral thesis "Genetic Studies of Tissue-Specific Mitochondrial DNA Segregation in Mammals" in Biomedicum Helsinki 1, Lecture Hall 2, February 26, 2016 at 12.

Timo Otonkoski is a partner in the recently launched IMI project INNODIA, aiming to identify new biomarkers and intervetions for type 1 diabetes. The project lasts for 7 years, has 33 partners from all around EU and a budget of 36,5 million euros. The role of the Otonkoski group is to develop stem-cell based experimental models for type 1 diabetes.

Anu Wartiovaara's publication "Stem Cells: Asymmetric rejuvenation" is one of the 2015 editor's choice of Nature

Sanna Toivonen from group Otonkoski defended her doctoral thesis "Derivation of hepatocyte like cells form human pluripotent stem cells" in Biomedicum Helsinki, Lecture Hall 2, January 22, 2016 at 12.

Kaisa Kyöstilä from group Lohi defended her doctoral thesis "Identification of novel mutations and molecular pathways for canine neurodegeneration and chondrodysplasia" in University Main Building, Auditorium XII, December 4, 2015 at 12.

Jani Saksi from group Lindsberg defended his doctoral thesis "Stroke-Associated Carotid Atherosclerosis - A Role for FABP4 in Atheroma Vulnerability and Cardiometabolic Risk" in Biomedicum Helsinki, Lecture Hall 2, December 4, 2015 at 13.

Jani Saksi from group Lindsberg has received the EAS Young Investigator Award in Basic Science for his publication "Low-Expression Variant of Fatty Acid–Binding Protein 4 Favors Reduced Manifestations of Atherosclerotic Disease and Increased Plaque Stability".

Welcome to Molecular Neurology Research Program!


Molecular Neurology Research Program is one of the five research programs in the University of Helsinki, Faculty of Medicine Research Programs Unit. We operate in the Research Programs Unit for the period 2013-2018. The program is led by Professor Anu Wartiovaara.

The research program's ambitious goal is to clarify the neurological and neuropsychiatric diseases mechanisms. We are looking for disease susceptibility genes by using cultured cells, disease models and patient samples. The molecular understanding about the diseases is a prerequisite for the search of potential drugs and therapies. We work closely with children's and adult neurology clinics, which enables the efficient use of research findings in the diagnosis, patient treatment and patient counseling. The Molecular Neurology Research Program consists of nine research groups.